Market Insight

Wellvii announced FDA clearance for its BP Go blood pressure monitor, which uses a finger-based sensor to measure blood pressure rather than the traditional inflatable arm cuff, and is designed for home and remote-care monitoring settings.
BP Go runs on the same finger-based NIBP algorithm as Wellvii

VB Spine has completed its acquisition of exclusive rights to Augmedics' CT-to-fluoroscopy technology for spine applications and plans to integrate it into its xvision Spine System platform. The deal builds on VB Spine's April acquisition of exclusive rights to the xvision platform itself, also from

The FDA has granted OncoSil Medical a humanitarian device exemption for its OncoSil system to treat distal cholangiocarcinoma, a rare bile duct cancer. The Australian company's device delivers targeted beta radiation directly into tumors via endoscopic ultrasound-guided injection, aiming to destroy

From organ preservation and AI-powered MSK care to autonomous imaging, respiratory monitoring and ultrasound BCI, this week’s MedTech funding activity highlights strong investor interest in technologies targeting clinical efficiency, earlier diagnosis and more accessible care. Read more below.
As an

Noah Medical has launched Galaxy II, updated software for its Galaxy robotic-assisted bronchoscopy platform used to biopsy small, hard-to-reach lung lesions. The system's core feature is Dual-Mode Imaging, letting physicians switch between High-Definition Digital Tomosynthesis and Cone-Beam CT mid-p

Calidar has closed out its first-in-human study of the Eidos Prism, a device that adds Volumetric X-Ray Diffraction, marketed as 4D Mammography, to existing 3D mammography systems. The study enrolled 61 patients at Baptist Health Hardin in Elizabethtown, Kentucky. Two manuscripts covering the device

Bridge to Life has closed $110 million in Series C equity and debt financing, led by new investor Soleus Capital alongside Lauxera Capital Partners and participation from company directors, officers, and employees. Soleus Capital Credit Opportunities Fund provided the debt portion. The funds will ex

Versa Vascular has expanded its Series C financing by $15 million, bringing total committed capital for the round to $42 million. The Santa Cruz-based company develops a transcatheter tricuspid repair device called AdapTR, and the new funding will support an ongoing first-in-human study outside the

Finnish medtech company Maculaser has closed a €4.4 million (roughly $5 million) funding round, following a first close announced in May. ZEISS Ventures and M2care co-led the round, joined by Innovestor, Metsola Ventures, and existing shareholders, plus non-dilutive R&D funding from Business Finland